ANXIETY is the #6 most commonly reported adverse reaction for Abilify Maintena, manufactured by Otsuka America Pharmaceutical, Inc.. There are 2,077 FDA adverse event reports linking Abilify Maintena to ANXIETY. This represents approximately 2.1% of all 96,636 adverse event reports for this drug.
Patients taking Abilify Maintena who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
ANXIETY2,077 of 96,636 reports
ANXIETY is a less commonly reported adverse event for Abilify Maintena, but still significant enough to appear in the safety profile.
Other Side Effects of Abilify Maintena
In addition to anxiety, the following adverse reactions have been reported for Abilify Maintena:
ANXIETY has been reported as an adverse event in 2,077 FDA reports for Abilify Maintena. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is ANXIETY with Abilify Maintena?
ANXIETY accounts for approximately 2.1% of all adverse event reports for Abilify Maintena, making it a notable side effect.
What should I do if I experience ANXIETY while taking Abilify Maintena?
If you experience anxiety while taking Abilify Maintena, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.